Phase I-II

Survey: about half of trials will be decentralized in the next 12 months

08-Sep-2021 By Jenni Spinner

A survey on remote patient monitoring, conducted by health solutions firm Vivalink, anticipates notable growth in virtual studies during the next year

Increasingly savvy patients call for shift in trial approach: Illingworth

07-Sep-2021 By Jenni Spinner

A leader from the home trial services provder says patients’ increasing awareness of clinical research has how trial teams should consider their approach.

Statistical innovation could elevate global clinical trials: Cytel

07-Sep-2021 By Jenni Spinner

The trial tech firm says analysis of trials in low- and middle-income regions reveals that innovative statistical methods could make a huge difference.

Curebase to partner on VR-based chronic pain clinical trials

02-Sep-2021 By Jenni Spinner

The decentralized trial tech firm will work with Applied VR on five studies testing the viability of virtual-reality therapy in treating pain patients.

People on the Move: September 2021

02-Sep-2021 By Jenni Spinner

This month’s news on new hires, board launches, acquisitions, and other important news includes items on Pfizer, Javara, Clinical Ink, and other companies.

Survey: cancer patients missing out on much-needed genetic testing

31-Aug-2021 By Jenni Spinner

According to patient-matching specialist TrialJectory, 90% of cancer patients know the vitality of genetic testing but more than half are not being tested.

Partnership fights to amplify Black women’s voice in breast cancer research

31-Aug-2021 By Jenni Spinner

The #BlackDataMatters movement aims to improve outcomes for Black women living with breast cancer by increasing their presence in vital clinical research.

Merck to collaborate with Ontada on data-driven cancer insights

26-Aug-2021 By Jenni Spinner

Merck (known as MSD outside the US and Canada) will partner with the data insights firm on solutions that progress real-world research and innovations.

Report reveals obstacles to implementing digital trial tech

26-Aug-2021 By Jenni Spinner

A study conducted by trial tech firms Curedatis and Climedo Health reveals what trial professionals view as challenges and opportunities in digitalization.

Chikungunya vaccine candidate enters Phase 2/3 trial

26-Aug-2021 By Rachel Arthur

The International Vaccine Institute (IVI) and Bharat Biotech have started a Phase 2/3 clinical trial for a chikungunya vaccine candidate in Costa Rica.

Avera Health, Sema4 join forces on precision cancer care

24-Aug-2021 By Jenni Spinner

The regional US healthcare system will collaborate with the health intelligence specialist to advance precision medicine focused on oncological care.

Uniting clinical research, healthcare can benefit both: Biofourmis

17-Aug-2021 By Jenni Spinner

An executive from the digital therapeutics specialist discusses the clinical trial landscape, and how clinical care can yield a number of important benefits.

Trial complexity, info explosion driving data management evolution

17-Aug-2021 By Jenni Spinner

A leader from Veeva Systems shares perspective on what factors are impacting clinical trial data management, and how the industry can adapt to the changes.

Tech Innovations: August 2021

17-Aug-2021 By Jenni Spinner

This month’s roundup of equipment, decentralized technology, partnerships and other items includes news from Medidata, PerkinElmer, Syneos and other firms.

Alzheimer’s research tool targets underrepresented groups

16-Aug-2021 By Emily Jarecki

The National Institute on Aging has launched Outreach Pro, an online tool aimed to help connect with underrepresented populations for Alzheimer’s trials.

Accenture survey reflects changing patient experiences

16-Aug-2021 By Jenni Spinner

The check-in with nearly 1,800 US healthcare consumers reflects how COVID-19 and other factors have impacted patient access, equity, experience and trust.

WHO COVID-19 trial moves ahead with three drug candidates

12-Aug-2021 By Jenni Spinner

The World Health Organization’s Solidarity PLUS trial will kick off in 52 countries, trialing three drugs to treat patients hospitalized with COVID-19.

TriNetX, Marshfield Clinic Research Institute partner to improve trial access

12-Aug-2021 By Emily Jarecki

The clinical study network is partnering with the Wisconsin-based health system to increase the reach of trials into a largely rural patient population.

Importance of achieving true patient centricity in clinical trials

09-Aug-2021 By Jenni Spinner

A leader from Longboat by Advarra outlines what it really means for a study to be patient centric, and how to succeed in achieving patient-centric trials.

Understanding placebo response, patient personality vital

09-Aug-2021 By Jenni Spinner

A representative from Tools4Patient discusses how grasping the ties between the two can help in reducing the impact of the placebo response in trials.

Artificial intelligence stands to ‘revolutionize’ research: Bioclinica

05-Aug-2021 By Jenni Spinner

A leader from the clinical research tech specialist explains how the use of AI is increasing and outlines the many ways it could change the field.

cphi north america 2021

Pharma event welcomes industry professionals ‘keen to meet’

04-Aug-2021 By Jenni Spinner

Producers of CPhI North America 2021 offer a glimpse at programming, including sessions on COVID-19 challenges, supply chain issues, and more key topics.

Psychedelics research institute launches in Australia

03-Aug-2021 By Jenni Spinner

The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.

AstraZeneca lupus treatment Saphnelo obtains FDA approval

02-Aug-2021 By Jenni Spinner

The drug, intended for adult patients with moderate-to-severe systemic lupus erythematosus, is the only new therapy approved for SLE in more than a decade.

Treg cell therapy showing promise in ALS trials: Coya Therapeutics

02-Aug-2021 By Jenni Spinner

According to the neurodegenerative-disease-focused biotechnology firm, their research could bring hope to patients with amyotrophic lateral sclerosis.

Arcturus Therapeutics lines up Phase 1/2/3 trial for next-generation mRNA COVID-19 vaccine

02-Aug-2021 By Rachel Arthur

Arcturus Therapeutics and its Vietnam partner Vinbiocare will take ARCT-154, a next-generation Arcturus vaccine targeting SARS-CoV-2 variants of concern, into a Phase 1/2/3 trial. The companies will also establish a vaccine manufacturing centre in Vietnam....

FDA grants Breakthrough Device designation to digital therapeutic

29-Jul-2021 By Jenni Spinner

The BiovitalsHF, from Biofourmis, is intended to augment decision-making in clinical environments, and to supplement traditional pharmaceutical therapies.

Pharma industry, CROs adapting to COVID-19 impacts: survey

27-Jul-2021 By Jenni Spinner

A recent check-in with several biopharma and CRO companies, conducted by Life Science Strategy Group, indicates adjustment to pandemic-related challenges.

BMS, BridgeBio partner to study drug combo for lung cancer

27-Jul-2021 By Jenni Spinner

The two pharma firms will partner to study the efficacy of Opdivo, paired with a SHP2 inhibitor, to treat non-small cell lung cancer with KRAS mutations.

Recent FDA actions and responses on COVID-19 pandemic

26-Jul-2021 By Jenni Spinner

The US Food and Drug Administration has stayed on top of developments around the pandemic, including research into potential vaccines and treatments.

Personalized medicine requires complex supply chains: Marken

26-Jul-2021 By Jenni Spinner

A clinical trial logistics expert discusses specialized concerns involved in transporting cell and gene products and other personalized medicine items.

Merck, Evidation join forces on Alzheimer’s data solutions

22-Jul-2021 By Jenni Spinner

The health data specialist and pharma firm are partnering on solutions around remote collection of digital data for detection and monitoring of treatments.

Next-level tech elevates clinical data management: AiCure

22-Jul-2021 By Jenni Spinner

A leader from the artificial intelligence solutions firm discusses how advanced analytical tools can help researchers make the most of mountains of data.

Novartis inks 10-year pledge to improve equity in research, care

20-Jul-2021 By Jenni Spinner

The pharma firm's partnership with 26 US Black colleges includes a $13.7m investment in trial and research centers at Morehouse School of Medicine.

Statins may reduce risk of COVID-19 death: researchers

19-Jul-2021 By Jenni Spinner

A recent study indicates patients taking the cholesterol-lowering drugs prior to COVID hospitalization are far less likely to die as a result of the virus.

WHO issues position statement on TB clinical trial design

19-Jul-2021 By Jenni Spinner

The World Health Organization hopes to encourage the development of novel therapies for tuberculosis by spotlighting key clinical study characteristics.

COTA, MedStar Health partnership to use RWD in cancer research

15-Jul-2021 By Jenni Spinner

The oncology-centered analytics firm will work with the DC-area healthcare provider to delve into discovery and development of novel cancer treatments.

Savvy solutions can elevate medication adherence: AARDEX

14-Jul-2021 By Jenni Spinner

A representative from the medication management solutions company suggests patient behavior data can be used to improve adherence to trial drug regimens.

Ongoing training fills data management knowledge gaps: TriTiCon

14-Jul-2021 By Jenni Spinner

A leader from the clinical tech consultancy shares advice on how to employ training to help keep up with the rapidly evolving field of data management.

ACD/Labs, Science Data Experts establish AI partnership

14-Jul-2021 By Jenni Spinner

The two companies will work together to come up with solutions that use machine learning and artificial intelligence to help accelerate innovation in R&D.

From hesitancy to reliance: journey to real-world data acceptance

14-Jul-2021 By Jenni Spinner

According to a leader from CRO Quanticate, the research industry’s increased use of real-world data is leading to a broad range of benefits in trial work.

The right questions and tools key to clinical data: Daelight

14-Jul-2021 By Jenni Spinner

A leader from life-sciences IT consultancy Daelight Solutions shares how the clinical trial data landscape has changed and offers advice on how to keep up.

ReiThera’s COVID-19 vaccine looks to Phase 3 trial after preliminary Phase 2 data

12-Jul-2021 By Rachel Arthur

Antibody responses against the SARS-CoV-2 spike protein were found in 99% of volunteers after the second dose of ReiThera’s COVID-19 vaccine candidate, according to Phase 2 preliminary data.

Rare disease specialists talk resources, research and hope

09-Jul-2021 By Jenni Spinner

During the Rare/Orphan Diseases, Special Patient Population webinar, a group of industry experts discussed challenges and opportunities faced in the field.

Pharma SAAS solutions must balance safety, efficiency: IQVIA

09-Jul-2021 By Jenni Spinner

A leader from IQVIA suggests what to look for when seeking ways to automate drug safety processes, while maintaining security and customer satisfaction.

CRO Parexel to be acquired by Goldman Sachs in $8.5b deal

08-Jul-2021 By Jenni Spinner

The global contract research organization has announced it will be purchased by Goldman Sachs Asset Management and EQT Private Equity.

People on the Move: July 2021

08-Jul-2021 By Jenni Spinner

This month’s news on hires, promotions, acquisitions, and expansions includes items about Javara, Elligo, Lonza, Yourway, Medable, and other notable firms.

Duke University, HumanFirst partner to assess digital clinical measuring tools

06-Jul-2021 By Jenni Spinner

The two entities will work together to evaluate digital sensors and other tools used in clinical research, checking the items for accuracy and equity.

BMS, GRYT Health collaborate on patient advocacy platform

06-Jul-2021 By Jenni Spinner

The two organizations have joined to create the Advocacy Exchange, a virtual platform designed to bring together patients, advocates and industry leader.

Experts to talk rare and orphan diseases, patient experience at webinar

01-Jul-2021 By Jenni Spinner

On July 7, a group of seasoned industry leaders will offer insights at Rare/orphan diseases, special patient population, a focused, free online event.